文献速递母胎医学

胎盘胎儿嵌合体对性染色体非整倍体无创产前检测的影响

Implications of fetoplacental mosaicism on cell-free DNA testing for sex chromosome aneuploidies.
PubMed 文献 · Prenat Diagn · 2017-09-06

该回顾性分析基于67 030例绒毛膜绒毛取样核型,预测性染色体非整倍体因胎盘胎儿嵌合体所致的cfDNA检测假阳性率约0.05%,非嵌合性性染色体非整倍体假阴性率0%~5.7%,而超声正常的嵌合型45,X假阴性率高达70%。羊水细胞预测PPV多数性染色体非整倍体为94.4%~99.4%,但无超声异常的45,X的PPV仅51%或71%,显著低于有超声异常者的99%。

要点

  • 胎盘胎儿嵌合体是性染色体非整倍体cfDNA检测的主要问题,咨询时仍需强调产前确认。
  • 无超声异常时,优先选择羊膜腔穿刺进行产前确认。
  • PPV随超声异常与否而变化,熟练的超声评估至关重要。

核心结论

  • 嵌合体是性染色体非整倍体cfDNA检测的主要问题,产前确认仍然重要,无超声异常时优先选择羊膜腔穿刺。
  • PPV因是否存在超声异常而变化,熟练的评估至关重要。

研究设计与样本

  • 回顾性分析67 030例绒毛膜绒毛取样核型,包括胎盘胎儿嵌合体病例。

主要发现

  • 非嵌合型45,X与囊性水瘤/颈项透明层增厚及胎儿畸形相关。
  • 因局限性胎盘嵌合体所致的假阳性率预计为0.05%。
  • 所有非嵌合性性染色体非整倍体的估计假阴性率范围为0%~5.7%;超声正常的嵌合型45,X的假阴性率为70%。
  • 羊水细胞预测PPV对大多数性染色体非整倍体很高(94.4%~99.4%)。
  • 分层分析显示,无超声异常的45,X的PPV为51%或71%,而有超声异常者为99%,前者远低于后者。

临床怎么用

  • 咨询时应告知嵌合体是性染色体非整倍体cfDNA检测的主要问题,并强调产前确认的重要性。
  • 无超声异常时,产前确认优先选择羊膜腔穿刺。
  • 因PPV随超声异常与否而变化,应进行熟练的超声评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The unique biological behavior of sex chromosomes has implications for cell-free DNA (cfDNA) testing. Our purpose is to predict the (1) false positive/negative rates of cfDNA testing consequent to fetoplacental mosaicism for any sex chromosome aneuploidies (SCA) and (2) positive predictive value (PPV) and negative predictive values of a high-risk and low-risk cfDNA result for any SCA. METHOD: This is a retrospective analysis of 67 030 chorionic villus sampling karyotypes, including fetoplacental mosaicism cases. RESULTS: Non-mosaic 45, X is associated with cystic hygroma/increased nuchal translucency and fetal anomalies. The false positive rate consequent to confined placental mosaicism is predicted to be 0.05%. The estimated false negative rate is in the range of 0% to 5.7% for all non-mosaic SCAs; it is 70% for mosaic 45, X with normal ultrasound. The predicted PPV on amniocytes is very high for most SCAs (94.4-99.4%). However, the stratified analysis shows that the PPV is much lower for 45, X without ultrasound anomalies compared with 45, X with abnormal scan (51% or 71%, vs 99%, respectively). CONCLUSION: Mosaicism is a major issue for SCA cfDNA testing, and prenatal confirmation, preferentially with amniocentesis if there are no ultrasound anomalies, remains important in counseling. As PPV varies on the basis of the presence of an ultrasound anomaly, skilled evaluation is critical. © 2017 John Wiley & Sons, Ltd.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Grati FR, Bajaj K, Zanatta V, et al. Implications of fetoplacental mosaicism on cell-free DNA testing for sex chromosome aneuploidies. Prenat Diagn. 2017. PMID: 28801976. doi:10.1002/pd.5138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。